Chargement en cours...
Retrospective analysis of the effect of CAPOX and mFOLFOX6 dose intensity on survival in colorectal patients in the adjuvant setting
BACKGROUND: Despite lack of a true comparative study, the folfox (5-fluorouracil–leucovorin–oxaliplatin) and capox (capecitabine–oxaliplatin) regimens are believed to be similar in their efficacy and tolerability in the treatment of stage iii colorectal cancer. However, that belief has been disputed...
Enregistré dans:
| Publié dans: | Curr Oncol |
|---|---|
| Auteurs principaux: | , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Multimed Inc.
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4900828/ https://ncbi.nlm.nih.gov/pubmed/27330345 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.23.3059 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|